{"id":40057,"date":"2023-06-02T09:01:49","date_gmt":"2023-06-02T09:01:49","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=40057"},"modified":"2025-11-18T08:02:19","modified_gmt":"2025-11-18T08:02:19","slug":"pace-customized-cxl-osn-ocular-surgery-news","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/pace-customized-cxl-osn-ocular-surgery-news\/","title":{"rendered":"Relat\u00f3rios da OSN sobre o CXL personalizado PACE"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Emilio Torres-Netto, MD, PhD<\/a> falou \u00e0 Not\u00edcias de Cirurgia Ocular<\/a> sobre os dados que apresentou na reuni\u00e3o de Inverno da ESCRS 2023<\/a> em Vilamoura, Portugal. Ele apresentou os dados mais recentes do Instituto ELZA sobre o m\u00e9todo de cross-linking corneano personalizado (CXL) de segunda gera\u00e7\u00e3o conhecido como PACE (reticula\u00e7\u00e3o epi-on assistida por PTK)<\/a>De acordo com o Dr. Torres-Netto, o PACE poder\u00e1 estar a abrir caminho para uma mudan\u00e7a de paradigma na gest\u00e3o da ectasia da c\u00f3rnea, o que poder\u00e1 levar a melhores resultados visuais, bem como a travar os processos de doen\u00e7a envolvidos nas ectasias da c\u00f3rnea, como o ceratocone.<\/p>\n

Com o PACE, \u00e9 aplicada uma maior quantidade de irradia\u00e7\u00e3o na \u00e1rea da c\u00f3rnea onde se encontra o cone de ceratocone e \u00e9 utilizada uma menor quantidade de irradia\u00e7\u00e3o no resto da c\u00f3rnea. Trata-se de uma abordagem CXL personalizada que \u00e9 adaptada \u00e0 c\u00f3rnea de cada doente. A abordagem PACE cria um gradiente que aplana selectivamente a \u00e1rea mais \u00edngreme do ceratocone de forma significativa. Como explica o Dr. Torres-Netto, isto resulta numa quantidade significativa de aplana\u00e7\u00e3o da c\u00f3rnea que aparece ap\u00f3s apenas algumas semanas.<\/p>\n

O Dr. Torres-Netto enfatizou as vantagens do PACE, explicando que ele n\u00e3o apenas regulariza a c\u00f3rnea, mas tamb\u00e9m modifica sua curvatura para melhorar a vis\u00e3o. \"Num caso aqui apresentado, obtivemos um efeito de achatamento de 7 D em poucas semanas, que se manteve est\u00e1vel nos meses seguintes\", disse Torres-Netto \u00e0 OSN.<\/p>\n

As implica\u00e7\u00f5es do PACE s\u00e3o de grande alcance, especialmente quando se considera pacientes com cataratas e ceratocone. \"Se tivermos um paciente com catarata e ceratocone, podemos primeiro melhorar a c\u00f3rnea com o PACE e depois calcular a LIO com mais precis\u00e3o e at\u00e9 utilizar uma LIO t\u00f3rica\", explicou Torres-Netto \u00e0 OSN. Este desenvolvimento empolgante poder\u00e1 conduzir a melhores resultados visuais para os doentes que anteriormente tinham dificuldade em encontrar solu\u00e7\u00f5es eficazes.<\/p>\n

Embora sejam necess\u00e1rios mais dados para avaliar totalmente o impacto do PACE cross-linking, os resultados apresentados na confer\u00eancia de Inverno da ESCRS geraram um enorme entusiasmo neste dom\u00ednio. O CXL personalizado PACE parece estar pronto para mudar o panorama do tratamento do ceratocone e melhorar a vida de in\u00fameros pacientes. Fique atento a mais dados que ser\u00e3o apresentados na reuni\u00e3o principal da ESCRS no final deste ano em Viena.<\/p>\n

<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\n\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

TRANSCRI\u00c7\u00c3O:<\/span><\/p>

Ol\u00e1, o meu nome \u00e9 Emilio Torres e estou a falar-vos a partir da confer\u00eancia de Inverno ESCRS 2023 em Portugal. Hoje, estamos a apresentar um caso de um paciente que conseguiu melhorar significativamente a regularidade da sua c\u00f3rnea usando uma nova tecnologia de cross-linking.<\/p>

Tradicionalmente, o cross-linking tem sido usado para estabilizar a c\u00f3rnea, particularmente em pacientes com ceratocone avan\u00e7ado. No entanto, com a segunda gera\u00e7\u00e3o de cross-linking personalizado, conhecido como PACE ou PTK-assisted epi-on corneal cross-linking, podemos agora n\u00e3o s\u00f3 estabilizar a c\u00f3rnea, mas tamb\u00e9m melhorar a sua curvatura.<\/p>

No caso que apresent\u00e1mos, o doente sentiu um efeito de aplana\u00e7\u00e3o de at\u00e9 7 dioptrias em poucas semanas de tratamento, que se manteve est\u00e1vel ap\u00f3s alguns meses. Embora ainda seja necess\u00e1rio recolher mais dados, esta nova tecnologia tem o potencial de mudar os paradigmas neste dom\u00ednio.<\/p>

Por exemplo, imagine um paciente com cataratas e ceratocone. Com o PACE cross-linking, poder\u00edamos primeiro melhorar a c\u00f3rnea e depois calcular com maior precis\u00e3o e at\u00e9 utilizar uma lente intra-ocular t\u00f3rica.<\/p>

De um modo geral, estamos muito entusiasmados com os resultados do PACE cross-linking e esperamos apresentar mais dados na nossa principal reuni\u00e3o da ESCRS este ano em Viena. Muito obrigado.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Emilio Torres-Netto, MD, PhD spoke to Ocular Surgery News about the data he presented at the Winter ESCRS 2023 meeting in Vilamoura, Portugal. He presented the ELZA Institute’s latest data on the second-generation customized corneal cross-linking (CXL) method known as PACE (PTK-assisted epi-on cross-linking). According to Dr. Torres-Netto, PACE could be paving the way for […]<\/p>\n","protected":false},"author":4,"featured_media":40074,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[243,97,96,10],"tags":[209,130,632,100,133,134,633,635,624,634,625,111,866],"class_list":["post-40057","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-emilio-torres","category-podium-power","category-popular-press","category-video-interviews","tag-basic-research","tag-cross-linking","tag-customized","tag-cxl","tag-epi-off","tag-epi-on","tag-flattening","tag-laser","tag-pace","tag-ptk","tag-refractive","tag-refractive-laser-surgery","tag-video-interview"],"acf":[],"yoast_head":"\nOSN reports on PACE customized CXL<\/title>\n<meta name=\"description\" content=\"Emilio Torres-Netto and PACE: customized CXL. Its potential impact on keratoconus treatment, showcased at the Winter ESCRS 2023 conference.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/pace-customized-cxl-osn-ocular-surgery-news\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OSN reports on PACE customized CXL\" \/>\n<meta property=\"og:description\" content=\"Emilio Torres-Netto and PACE: customized CXL. Its potential impact on keratoconus treatment, showcased at the Winter ESCRS 2023 conference.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/pace-customized-cxl-osn-ocular-surgery-news\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-02T09:01:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-18T08:02:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/04\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"OSN reports on PACE customized CXL\",\"datePublished\":\"2023-06-02T09:01:49+00:00\",\"dateModified\":\"2025-11-18T08:02:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/\"},\"wordCount\":550,\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg\",\"keywords\":[\"Basic Research\",\"Cross-Linking\",\"customized\",\"CXL\",\"epi-off\",\"epi-on\",\"flattening\",\"laser\",\"pace\",\"PTK\",\"refractive\",\"Refractive Laser Surgery\",\"Video Interview\"],\"articleSection\":[\"Emilio Torres\",\"Podium Power\",\"Popular press\",\"Video Interview\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/\",\"name\":\"OSN reports on PACE customized CXL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg\",\"datePublished\":\"2023-06-02T09:01:49+00:00\",\"dateModified\":\"2025-11-18T08:02:19+00:00\",\"description\":\"Emilio Torres-Netto and PACE: customized CXL. Its potential impact on keratoconus treatment, showcased at the Winter ESCRS 2023 conference.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg\",\"width\":1200,\"height\":600,\"caption\":\"PACE: Customized CXL ar Winter ESCRS\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pace-customized-cxl-osn-ocular-surgery-news\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emilio Torres\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/de-ch\\\/emilio-torres\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"OSN reports on PACE customized CXL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.elza-institute.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ELZA.Institute\\\/\",\"https:\\\/\\\/x.com\\\/ELZA_Institute\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/pt\\\/author\\\/markhillen\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Relat\u00f3rios da OSN sobre o CXL personalizado PACE","description":"Emilio Torres-Netto e PACE: CXL personalizado. O seu potencial impacto no tratamento do ceratocone, apresentado na confer\u00eancia de inverno ESCRS 2023.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/pace-customized-cxl-osn-ocular-surgery-news\/","og_locale":"pt_PT","og_type":"article","og_title":"OSN reports on PACE customized CXL","og_description":"Emilio Torres-Netto and PACE: customized CXL. Its potential impact on keratoconus treatment, showcased at the Winter ESCRS 2023 conference.","og_url":"https:\/\/www.elza-institute.com\/pt\/pace-customized-cxl-osn-ocular-surgery-news\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2023-06-02T09:01:49+00:00","article_modified_time":"2025-11-18T08:02:19+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/04\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"OSN reports on PACE customized CXL","datePublished":"2023-06-02T09:01:49+00:00","dateModified":"2025-11-18T08:02:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/"},"wordCount":550,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/04\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg","keywords":["Basic Research","Cross-Linking","customized","CXL","epi-off","epi-on","flattening","laser","pace","PTK","refractive","Refractive Laser Surgery","Video Interview"],"articleSection":["Emilio Torres","Podium Power","Popular press","Video Interview"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/","url":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/","name":"Relat\u00f3rios da OSN sobre o CXL personalizado PACE","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/04\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg","datePublished":"2023-06-02T09:01:49+00:00","dateModified":"2025-11-18T08:02:19+00:00","description":"Emilio Torres-Netto e PACE: CXL personalizado. O seu potencial impacto no tratamento do ceratocone, apresentado na confer\u00eancia de inverno ESCRS 2023.","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/04\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/04\/Emilio-Torres-Netto-PACE-Custom-CXL-Winter-ESCRS-2023-featured-image.jpg","width":1200,"height":600,"caption":"PACE: Customized CXL ar Winter ESCRS"},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/pace-customized-cxl-osn-ocular-surgery-news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Emilio Torres","item":"https:\/\/www.elza-institute.com\/de-ch\/emilio-torres\/"},{"@type":"ListItem","position":3,"name":"OSN reports on PACE customized CXL"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/40057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=40057"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/40057\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/40074"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=40057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=40057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=40057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}